WeVote
Log In

Bill

Bill

S 6736

Relates to requiring Medicaid to cover a wearable medical device to treat certain forms of cancer

2025 Regular Session Introduced by Pat Fahy

Bill S 6736 mandates Medicaid to cover a wearable device for treating specific cancers, improving access to innovative treatments for eligible patients.

DELIVERED TO ASSEMBLY
0
WeVote Research Nonpartisan
Bill Summary · S 6736

Summary of Bill S 6736

Bill Overview

  • Bill Number: S 6736
  • Title: Relates to requiring Medicaid to cover a wearable medical device to treat certain forms of cancer
  • Status: Referred to Health
  • Introduced On: March 21, 2025
  • Classification: Bill

Purpose and Intent

The primary purpose of Bill S 6736 is to mandate that Medicaid, the state and federal program that provides health coverage to eligible low-income individuals, includes coverage for a specific wearable medical device designed to treat certain forms of cancer. This initiative aims to enhance treatment options for cancer patients who are enrolled in Medicaid, potentially improving health outcomes and quality of life.

Key Provisions

  • Medicaid Coverage Requirement: The bill stipulates that Medicaid must cover the costs associated with a designated wearable medical device that is effective in treating specific types of cancer.
  • Device Specifications: While the bill does not detail the specifications of the wearable device, it implies that the device must be clinically validated for the treatment of the specified cancer forms.
  • Implementation Timeline: The bill does not specify an exact timeline for implementation, but it is expected that Medicaid will need to adjust its policies and reimbursement structures accordingly once the bill is enacted.

Affected Parties

  • Cancer Patients: Individuals diagnosed with certain forms of cancer who are eligible for Medicaid will benefit from this coverage, gaining access to innovative treatment options that may not have been previously available to them.
  • Healthcare Providers: Medical professionals prescribing the wearable device will need to be aware of the new coverage to inform their patients about treatment options.
  • Medicaid Program: The bill will require adjustments to Medicaid's coverage policies and potentially its budget, depending on the cost of the device and the number of patients who will utilize it.

Legislative Actions

  • March 21, 2025: Bill introduced and referred to the Health Committee.
  • May 19, 2025: The bill was amended and recommitted to the Health Committee, with a new print number (6736A).
  • May 28, 2025: Reported and committed to the Finance Committee.
  • June 9, 2025: The committee was discharged and the bill was committed to Rules, ordered to third reading, and subsequently passed in the Senate.
  • June 9, 2025: Delivered to the Assembly and referred to the Health Committee for further consideration.

Related Legislation

  • A 6935: This bill serves as a companion to S 6736, indicating that similar provisions may be considered in the Assembly.

Conclusion

Bill S 6736 represents a significant step towards improving cancer treatment accessibility for Medicaid recipients. By requiring coverage for a wearable medical device, the bill aims to enhance patient care and treatment efficacy for those battling cancer. The ongoing legislative process will determine the final form and implementation of this important healthcare initiative.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.